cDC1s mediate anti-tumor immunity by activating cytotoxic CD8+ T cells, cDC2s activate anti-tumor CD4+ T cells but this process is restricted by Tregs or other immunosuppressive factors (120). This evidence concerns the gene CD8A and neoplasm.